BioMerieux Net Long-Term Debt 2017-2024 | BMXMF
BioMerieux annual/quarterly net long-term debt history and growth rate from 2017 to 2024. Net long-term debt can be defined as the net amount of long term debt issued and repaid. This field is either calculated as the sum of the long term debt fields or used if a company does not report debt issued and repaid separately
- BioMerieux net long-term debt for the quarter ending December 31, 2024 was $0M, a 0% increase year-over-year.
- BioMerieux net long-term debt for the twelve months ending December 31, 2024 was $0M, a 0% increase year-over-year.
- BioMerieux annual net long-term debt for 2024 was $-0.081B, a 114.9% increase from 2023.
- BioMerieux annual net long-term debt for 2023 was $-0.038B, a 349.98% decline from 2022.
- BioMerieux annual net long-term debt for 2022 was $0.015B, a 125.42% decline from 2021.
| BioMerieux Annual Net Long-Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $-81 |
| 2023 | $-38 |
| 2022 | $15 |
| 2021 | $-59 |
| 2020 | $-154 |
| 2019 | $N/A |
| 2018 | $N/A |
| 2017 | $N/A |
| 2016 | $N/A |
| 2015 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $16.861B | $4.307B |
| bioM?rieux S.A. designs, develops, manufactures and markets systems in the field of vitro diagnostics. The company provides diagnostic solutions which determine the source of disease and contamination. It also offers solutions for managing infectious diseases, cancers and cardiovascular diseases in clinical applications. The company provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for the agri-food, cosmetics and pharmaceutical industries. bioM?rieux S.A. is based in Marcy L Etoile, France. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $138.024B | 25.89 |
| CVS Health (CVS) | United States | $80.885B | 10.05 |
| Elevance Health (ELV) | United States | $75.961B | 9.80 |
| Cencora (COR) | United States | $57.110B | 19.87 |
| DiDi Global (DIDIY) | China | $25.792B | 27.40 |
| Labcorp Holdings (LH) | United States | $20.561B | 16.68 |
| Natera (NTRA) | United States | $20.462B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.598B | 0.00 |
| CochLear (CHEOY) | Australia | $12.760B | 0.00 |
| Solventum (SOLV) | United States | $12.748B | 13.49 |
| ICON (ICLR) | Ireland | $11.757B | 10.93 |
| Revvity (RVTY) | United States | $11.304B | 19.45 |
| Viatris (VTRS) | United States | $10.481B | 3.60 |
| Medpace Holdings (MEDP) | United States | $8.988B | 23.87 |
| Sonic Healthcare (SKHHY) | Australia | $8.788B | 0.00 |
| Avantor (AVTR) | United States | $8.736B | 12.69 |
| HealthEquity (HQY) | United States | $8.317B | 36.43 |
| Charles River Laboratories (CRL) | United States | $7.584B | 14.86 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.355B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.851B | 28.56 |
| BrightSpring Health Services (BTSG) | United States | $3.527B | 32.35 |
| Sotera Health (SHC) | United States | $3.230B | 18.35 |
| Surgery Partners (SGRY) | United States | $2.799B | 36.40 |
| Alignment Healthcare (ALHC) | United States | $2.623B | 0.00 |
| Concentras Parent (CON) | United States | $2.543B | 14.70 |
| Organon (OGN) | United States | $2.485B | 2.64 |
| GeneDx Holdings (WGS) | United States | $2.331B | 89.77 |
| Progyny (PGNY) | United States | $1.992B | 43.85 |
| Ardent Health (ARDT) | United States | $1.991B | 8.49 |
| PACS (PACS) | United States | $1.897B | 0.00 |
| Premier (PINC) | United States | $1.719B | 13.05 |
| GoodRx Holdings (GDRX) | United States | $1.697B | 33.93 |
| Teladoc Health (TDOC) | United States | $1.388B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.285B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.100B | 8.37 |
| CareDx (CDNA) | United States | $1.058B | 16.53 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.911B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.848B | 291.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.761B | 7.13 |
| Nutex Health (NUTX) | United States | $0.632B | 9.57 |
| InnovAge Holding (INNV) | United States | $0.564B | 0.00 |
| Embecta (EMBC) | United States | $0.560B | 3.77 |
| SBC Medicals (SBC) | United States | $0.511B | 0.00 |
| LifeMD (LFMD) | United States | $0.497B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.473B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.472B | 10.63 |
| Omada Health (OMDA) | $0.463B | 0.00 | |
| So-Young (SY) | China | $0.455B | 0.00 |
| Enhabit (EHAB) | United States | $0.354B | 29.17 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.333B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.309B | 0.00 |
| Oncology Institute (TOI) | United States | $0.265B | 0.00 |
| Beauty Health (SKIN) | United States | $0.207B | 0.00 |
| DocGo (DCGO) | United States | $0.142B | 23.17 |
| Pheton Holdings (PTHL) | China | $0.136B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.102B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.072B | 0.00 |
| KindlyMD (NAKA) | United States | $0.071B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.047B | 0.00 |
| Biodesix (BDSX) | United States | $0.045B | 0.00 |
| ModivCare (MODV) | United States | $0.045B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |